2型糖尿病口服降糖药应用备案.pptVIP

* 研究结果显示诺瑞格列奈单药已经能够能好的控制血糖，联合用药组效果进一步加强。 * * * 按ADA/EASD标准(HbA1c7.0%),两组患者达标率为70%以上 以上从理论基础看瑞格列奈联合二甲双胍的优势，我们再看看联合二甲双胍，瑞格列奈与长效SU类格列美脲的头对头的研究 Bratisl Lek Listy. 2009;110(6):335-9. Evaluation of the repaglinide efficiency in comparison to the glimepiride in the type 2 diabetes patients poorly regulated by the metmorfine administration. Dimic D, Velojic Golubovic M, Antic S, Radenkovic S. Source Clinical Center Nis, Clinic ofEndocrinology, Diabetes and Metabolic Disorders, Nis, Serbia. drdragand@bankerinter.net Abstract OBJECTIVES: An impaired early phase of insulin secretion in the type 2 dia